Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jeffrey

Showing results (281-290 of 651) with videos related to

Pageof 66
Sort By:
Internal Medicine Journal|February 28, 2013
Tacrolimus-induced thrombotic microangiopathy in orthotopic liver transplant patients: case series of four patientsA Nwaba, G MacQuillan, L A Adams, et al.
Neuropharmacology|August 28, 2003
Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(4'-fluorophenyl)-3-(4'phenylphenoxy)propyl])sarcosinePierre J Mallorga, Jacinta B Williams, Marlene Jacobson, et al.
Immunology and Cell Biology|July 18, 2002
Immunological markers predicting outcome in patients with hepatitis C treated with interferon-alpha and ribavirinSilvia Lee, Gerry C Macquillan, Niamh M Keane, et al.
Gastroenterology|March 27, 2007
Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantationEdward J Gane, Peter W Angus, Simone Strasser, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 24, 2023
Ventral Tegmental Area M5 Muscarinic Receptors Mediate Effort-Choice Responding and Nucleus Accumbens Dopamine in a Sex-Specific Manner Eric J Nunes, Nardos Kebede, Joshua L Haight, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 19, 2015
Effects of VU0410120, a novel GlyT1 inhibitor, on measures of sociability, cognition and stereotypic behaviors in a mouse model of autismJessica A Burket, Andrew D Benson, Torrian L Green, et al.
Journal of Gastroenterology and Hepatology|April 23, 2002
Disease recurrence after liver transplantation in Western AustraliaIan F Yusoff, Anthony K House, W Bastiaan De Boer, et al.
Nuclear Medicine and Biology|October 31, 2009
[(18)F]Fallypride dopamine D2 receptor studies using delayed microPET scans and a modified Logan plotMohammed N Tantawy, Carrie K Jones, Ronald M Baldwin, et al.
Drug News & Perspectives|June 4, 2010
The antipsychotic potential of muscarinic allosteric modulationThomas M Bridges, Evan P LeBois, Corey R Hopkins, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 26, 2021
Frontal cortex genetic ablation of metabotropic glutamate receptor subtype 3 (mGlu<sub>3</sub>) impairs postsynaptic plasticity and modulates affective behaviorsMax E Joffe, Chiaki I Santiago, Sheryl Anne D Vermudez, et al.
Pageof 66

Showing results (281-290 of 651) with videos related to

Sort By:
Pageof 66
Internal Medicine Journal|February 28, 2013
Tacrolimus-induced thrombotic microangiopathy in orthotopic liver transplant patients: case series of four patientsA Nwaba, G MacQuillan, L A Adams, et al.
Neuropharmacology|August 28, 2003
Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(4'-fluorophenyl)-3-(4'phenylphenoxy)propyl])sarcosinePierre J Mallorga, Jacinta B Williams, Marlene Jacobson, et al.
Immunology and Cell Biology|July 18, 2002
Immunological markers predicting outcome in patients with hepatitis C treated with interferon-alpha and ribavirinSilvia Lee, Gerry C Macquillan, Niamh M Keane, et al.
Gastroenterology|March 27, 2007
Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantationEdward J Gane, Peter W Angus, Simone Strasser, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 24, 2023
Ventral Tegmental Area M5 Muscarinic Receptors Mediate Effort-Choice Responding and Nucleus Accumbens Dopamine in a Sex-Specific Manner Eric J Nunes, Nardos Kebede, Joshua L Haight, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 19, 2015
Effects of VU0410120, a novel GlyT1 inhibitor, on measures of sociability, cognition and stereotypic behaviors in a mouse model of autismJessica A Burket, Andrew D Benson, Torrian L Green, et al.
Journal of Gastroenterology and Hepatology|April 23, 2002
Disease recurrence after liver transplantation in Western AustraliaIan F Yusoff, Anthony K House, W Bastiaan De Boer, et al.
Nuclear Medicine and Biology|October 31, 2009
[(18)F]Fallypride dopamine D2 receptor studies using delayed microPET scans and a modified Logan plotMohammed N Tantawy, Carrie K Jones, Ronald M Baldwin, et al.
Drug News & Perspectives|June 4, 2010
The antipsychotic potential of muscarinic allosteric modulationThomas M Bridges, Evan P LeBois, Corey R Hopkins, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 26, 2021
Frontal cortex genetic ablation of metabotropic glutamate receptor subtype 3 (mGlu<sub>3</sub>) impairs postsynaptic plasticity and modulates affective behaviorsMax E Joffe, Chiaki I Santiago, Sheryl Anne D Vermudez, et al.
Pageof 66